Meetings

As the first installment in the 2026 Johnson&Johnson and Legend CAR T Series, join Dr. Joy Ho and Dr. Marco Davila as they explore the latest advances in in vivo CAR T cell therapy, offering insights from both clinical and translational research perspectives.

Sponsored by Johnson and Johnson and Legend Biotech.

TP53 mutated MDS and AML represent some of the most difficult diseases to treat, with poor prognosis. This webinar uses a case based approach to debate the best transplant approach (including no transplant) for older patients with TP53 mutated disease in different scenarios. 

The Clinical Education Conference (CEC) provides a deeper understanding of the diagnostic evaluations and therapeutic treatments for acute and chronic complications of hematopoietic cell transplantation and cellular therapies. During this two-day event, participate in breakout sessions that will dig deeper into case studies and treatments of either the adult or pediatric patient populations. In addition, the CEC offers a track specially designed for beginners (defined as at about one year into their careers in the field).

The Gene Therapy Summit is an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies focused on ex vivo gene therapy using hematopoietic stem cells.

The Toxicities of Transplantation and Cellular Therapies Conference brings together experts and thought leaders from around the world to discuss the mechanism of toxicities and symptom burden after hematopoietic cell transplantation (HCT) and cellular and gene therapies; current advances in the field; and best practices to both prevent and treat these toxicities and symptoms.